30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Current & Critical

JNJ Restructuring Expected to Impact DePuy Synthes

Johnson & Johnson (JNJ), parent company of DePuy Synthes, will undertake restructuring actions in its Medical Devices business, including changes to the orthopaedics segment. JNJ cited business exits and staff reductions as it seeks pre-tax cost savings of up to $1 billion by end of 2018. 

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.